相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Replicable in vivo physiological and behavioral phenotypes of the Shank3B null mutant mouse model of autism
Sameer C. Dhamne et al.
MOLECULAR AUTISM (2017)
The Stress-Induced Atf3-Gelsolin Cascade Underlies Dendritic Spine Deficits in Neuronal Models of Tuberous Sclerosis Complex
Duyu Nie et al.
JOURNAL OF NEUROSCIENCE (2015)
Contribution of mGluR5 to pathophysiology in a mouse model of human chromosome 16p11.2 microdeletion
Di Tian et al.
NATURE NEUROSCIENCE (2015)
Tuberous Sclerosis: A New Frontier in Targeted Treatment of Autism
Peter E. Davis et al.
NEUROTHERAPEUTICS (2015)
Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND Checklist
Petrus J. de Vries et al.
PEDIATRIC NEUROLOGY (2015)
Chronic Metabotropic Glutamate Receptor 5 Inhibition Corrects Local Alterations of Brain Activity and Improves Cognitive Performance in Fragile X Mice
Aubin Michalon et al.
BIOLOGICAL PSYCHIATRY (2014)
Mechanism based neurotoxicity of mGlu5 positive allosteric modulators - Development challenges for a promising novel antipsychotic target
Sophie Parmentier-Batteur et al.
NEUROPHARMACOLOGY (2014)
Long-Term Memory Deficits are Associated with Elevated Synaptic ERK1/2 Activation and Reversed by mGluR5 Antagonism in an Animal Model of Autism
Ronald R. Seese et al.
NEUROPSYCHOPHARMACOLOGY (2014)
In vitro characterisation of the novel positive allosteric modulators of the mGlu(5) receptor, LSN2463359 and LSN2814617, and their effects on sleep architecture and operant responding in the rat
Gary Gilmour et al.
NEUROPHARMACOLOGY (2013)
Reduced Juvenile Long-Term Depression in Tuberous Sclerosis Complex Is Mitigated in Adults by Compensatory Recruitment of mGluR5 and Erk Signaling
Wyatt B. Potter et al.
PLOS BIOLOGY (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features
Elizabeth Yuan et al.
HUMAN MOLECULAR GENETICS (2012)
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice
Peter T. Tsai et al.
NATURE (2012)
Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
Aubin Michalon et al.
NEURON (2012)
Negative Allosteric Modulation of the mGluR5 Receptor Reduces Repetitive Behaviors and Rescues Social Deficits in Mouse Models of Autism
Jill L. Silverman et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Mutations causing syndromic autism define an axis of synaptic pathophysiology
Benjamin D. Auerbach et al.
NATURE (2011)
CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor
Lothar Lindemann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats
Pavel Mares et al.
EPILEPSIA (2010)
mTOR signaling: At the crossroads of plasticity, memory and disease
Charles A. Hoeffer et al.
TRENDS IN NEUROSCIENCES (2010)
A hypomorphic allele of Tsc2 highlights the role of TSC1/TSC2 in signaling to AKT and models mild human TSC2 alleles
Kristen Pollizzi et al.
HUMAN MOLECULAR GENETICS (2009)
SUnSET, a nonradioactive method to monitor protein synthesis
Enrico K. Schmidt et al.
NATURE METHODS (2009)
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis
Dan Ehninger et al.
NATURE MEDICINE (2008)
Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers
Valerie Treyer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors:: Identification, in vitro pharmacology, pharmacokinetic and biodistribution studies
Samuel Hintermann et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models
GG Kinney et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
mGluS receptor antagonists: A novel class of anxiolytics?
W Spooren et al.
DRUG NEWS & PERSPECTIVES (2004)